Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples